These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 22435797

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial.
    Cooper C, Reginster JY, Chapurlat R, Christiansen C, Genant H, Bellamy N, Bensen W, Navarro F, Badurski J, Nasonov E, Chevalier X, Sambrook PN.
    Curr Med Res Opin; 2012 Feb; 28(2):231-9. PubMed ID: 22148897
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Generalized cutaneous drug eruption due to strontium ranelate.
    Boada A, Carrascosa JM, Leal L, Ferrándiz C.
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):321-2. PubMed ID: 18624862
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Strontium ranelate and risk of vertebral fractures in frail osteoporotic women.
    Rolland Y, Abellan Van Kan G, Gillette-Guyonnet S, Roux C, Boonen S, Vellas B.
    Bone; 2011 Feb; 48(2):332-8. PubMed ID: 20817053
    [Abstract] [Full Text] [Related]

  • 12. Strontium ranelate lives to fight another day.
    Compston J.
    Maturitas; 2014 Jun; 78(2):75-6. PubMed ID: 24780410
    [No Abstract] [Full Text] [Related]

  • 13. Protelos: nonvertebral and hip antifracture efficacy in postmenopausal osteoporosis.
    Adami S.
    Bone; 2006 Feb; 38(2 Suppl 1):23-7. PubMed ID: 16434247
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Strontium ranelate: the first agent of a new therapeutic class in osteoporosis.
    Neuprez A, Hiligsmann M, Scholtissen S, Bruyere O, Reginster JY.
    Adv Ther; 2008 Dec; 25(12):1235-56. PubMed ID: 19066755
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Alopecia associated with strontium ranelate use in a 62-year-old woman.
    Lee YY, Yang CH, Chen CH, Hwang JS.
    Osteoporos Int; 2013 Mar; 24(3):1127-9. PubMed ID: 22525979
    [Abstract] [Full Text] [Related]

  • 19. [Strontium ranelate in post-menopausal osteoporosis].
    Przedlacki J.
    Endokrynol Pol; 2011 Mar; 62 Suppl 2():23-31. PubMed ID: 22125019
    [Abstract] [Full Text] [Related]

  • 20. Clinically meaningful effect of strontium ranelate on symptoms in knee osteoarthritis: a responder analysis.
    Bruyère O, Reginster JY, Bellamy N, Chapurlat R, Richette P, Cooper C, SEKOIA investigators.
    Rheumatology (Oxford); 2014 Aug; 53(8):1457-64. PubMed ID: 24667161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.